Ticker: AXSM

Axsome Therapeutics, Inc. (NASDAQ: AXSM) continues to manage a challenging financial landscape while striving to expand its portfolio of central nervous system therapies. As of June 30, 2025, the company reported notable achievements in its income statement alongside areas of concern. Key Financi...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has released their quarterly report for the period ending March 31, 2025. The company is focused on developing innovative medicines for central nervous system (CNS) conditions and has experienced some notable developments in its financial standing and prod...